Cogora: The Agency – February digest

Cogora: The Agency continues to diversify its range of services for pharmaceutical and medical technology companies.

They have attended scientific sessions and symposia at European fertility conferences, out of which they are developing a plethora of educational materials covering the menopause and men’s healthcare. Women’s healthcare is also the focus of an upcoming probiotics roundtable, with a second one on the probiotics theme for antibiotic-associated diarrhoea.

Radiology professionals continue to be provided with webcasts on cardiovascular imaging.

The latest in the Agency’s series of KOL mapping tools is in its final stages of data checking, with discussions of how to maximise expert engagement in the immediate offing.

2026 marks the eighth year of The Agency’s engagement with the world of vascular access. Following news from a prestigious American journal of the acceptance of their most recent publication, a Faculty of European experts is advanced in the development of new, urgently needed assets. Watch this space.

Check out what the team were up to in January for more examples of how Cogora: The Agency delivers consistent value for its clients. For more information, please contact us.